B

Bolt Biotherapeutics
D

BOLT

5.77000
USD
-0.09
(-1.54%)
مغلق
حجم التداول
301
الربح لكل سهم
-26
العائد الربحي
-
P/E
-0
حجم السوق
11,075,175
أصول ذات صلة الأخبار المقالات

العنوان: Bolt Biotherapeutics Inc

القطاع: Healthcare
الصناعة: Biotechnology
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.